Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-04-021996
Filing Date
2004-04-26
Accepted
2004-04-26 20:48:09
Documents
1
Period of Report
2004-04-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3556
  Complete submission text file 0001209191-04-021996.txt   5329
Mailing Address 3031 RESEARCH DRIVE RICHMOND CA 94806
Business Address 3031 RESEARCH DR BLDG A RICHMOND CA 94806 5102229700
ONYX PHARMACEUTICALS INC (Issuer) CIK: 0001012140 (see all company filings)

EIN.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address ONYX PHARMACEUTICALS 3031 RESEARCH DRIVE RICHMOND CA 94806 5102628769
RENTON HOLLINGS (Reporting) CIK: 0001187333 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-28298 | Film No.: 04755455